down arrow

Rapid Micro Biosystems, Inc.

  • Market Cap: Micro Cap
  • Industry: Industrial Manufacturing
  • ISIN: US75340L1044
USD
4.03
-0.06 (-1.47%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

4.004.20

52 Week

0.874.50
Valuation
Technical
Day's Volume

CASH

103.16 k

Shareholding (Mar 2025)

FII

5.27%

Held by 8 FIIs

DII

61.08%

Held by 7 DIIs

Promoter

28.79%

How big is Rapid Micro Biosystems, Inc.?

22-Jun-2025

As of Jun 18, Rapid Micro Biosystems, Inc. has a market capitalization of 152.10 million, with net sales of 29.65 million and a net loss of 44.82 million over the last four quarters. Shareholder's funds total 75.35 million, and total assets are valued at 98.17 million.

Market Cap: As of Jun 18, Rapid Micro Biosystems, Inc. has a market capitalization of 152.10 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 29.65 million, while the sum of Net Profit shows a loss of 44.82 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the Shareholder's Funds amount to 75.35 million, and the Total Assets are valued at 98.17 million.

Read More

What does Rapid Micro Biosystems, Inc. do?

22-Jun-2025

Rapid Micro Biosystems, Inc. is a micro-cap company in the industrial manufacturing sector, reporting net sales of $7 million and a net loss of $11 million as of March 2025. Key financial metrics include a market cap of $152.10 million, a negative P/E ratio, and a dividend yield of 0%.

Overview: <BR>Rapid Micro Biosystems, Inc. operates in the industrial manufacturing sector and is classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Sales: 7 Million (Quarterly Results - Mar 2025) <BR>Net Profit: -11 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 152.10 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.62 <BR>Return on Equity: -68.45% <BR>Price to Book: 2.32<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Should I buy, sell or hold Rapid Micro Biosystems, Inc.?

22-Jun-2025

Is Rapid Micro Biosystems, Inc. technically bullish or bearish?

20-Sep-2025

As of July 29, 2025, Rapid Micro Biosystems, Inc. shows a mildly bullish trend with strong year-to-date and one-year returns of 257.78% and 283.33%, respectively, despite mixed signals from technical indicators.

As of 29 July 2025, the technical trend for Rapid Micro Biosystems, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a daily bullish moving average, while the weekly MACD and KST indicate a mildly bearish trend. The monthly Bollinger Bands and KST are bullish, but the Dow Theory shows a mixed signal with a mildly bearish monthly outlook. <BR><BR>In terms of performance, the company has significantly outperformed the S&P 500, with a year-to-date return of 257.78% compared to the S&P 500's 12.22%, and a one-year return of 283.33% versus 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Risky - Negative EBITDA

  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 277.27%, its profits have risen by 13.6%
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

USD 120 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.55

stock-summary
Return on Equity

-80.87%

stock-summary
Price to Book

2.20

Revenue and Profits:
Net Sales:
7 Million
(Quarterly Results - Jun 2025)
Net Profit:
-12 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
69.33%
0%
69.33%
6 Months
8.04%
0%
8.04%
1 Year
287.5%
0%
287.5%
2 Years
259.82%
0%
259.82%
3 Years
119.02%
0%
119.02%
4 Years
-65.76%
0%
-65.76%
5 Years
0%
0%
0.0%

Rapid Micro Biosystems, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Rapid Micro Biosystems, Inc. technically bullish or bearish?

As of 29 July 2025, the technical trend for Rapid Micro Biosystems, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by a daily bullish moving average, while the weekly MACD and KST indicate a mildly bearish trend. The monthly Bollinger Bands and KST are bullish, but the Dow Theory shows a mixed signal with a mildly bearish monthly outlook. In terms of performance, the company has significantly outperformed the S&P 500, with a year-to-date return of 257.78% compared to the S&P 500's 12.22%, and a one-year return of 283.33% versus 17.14%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
8.81%
EBIT Growth (5y)
-5.95%
EBIT to Interest (avg)
-41.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.62
Sales to Capital Employed (avg)
0.27
Tax Ratio
0.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
58.75%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.46
EV to EBIT
-2.55
EV to EBITDA
-2.74
EV to Capital Employed
4.81
EV to Sales
4.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-188.80%
ROE (Latest)
-68.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 7 Schemes (4.86%)

Foreign Institutions

Held by 8 Foreign Institutions (5.27%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 1.39% vs -12.20% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -5.31% vs -16.49% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.30",
          "val2": "7.20",
          "chgp": "1.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.30",
          "val2": "-10.80",
          "chgp": "-4.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-11.90",
          "val2": "-11.30",
          "chgp": "-5.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,672.80%",
          "val2": "-1,618.50%",
          "chgp": "-5.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 24.89% vs 31.58% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 10.67% vs 13.65% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28.10",
          "val2": "22.50",
          "chgp": "24.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-46.60",
          "val2": "-53.50",
          "chgp": "12.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-46.90",
          "val2": "-52.50",
          "chgp": "10.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,779.60%",
          "val2": "-2,511.80%",
          "chgp": "73.22%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
7.30
7.20
1.39%
Operating Profit (PBDIT) excl Other Income
-11.30
-10.80
-4.63%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-11.90
-11.30
-5.31%
Operating Profit Margin (Excl OI)
-1,672.80%
-1,618.50%
-5.43%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 1.39% vs -12.20% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -5.31% vs -16.49% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
28.10
22.50
24.89%
Operating Profit (PBDIT) excl Other Income
-46.60
-53.50
12.90%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-46.90
-52.50
10.67%
Operating Profit Margin (Excl OI)
-1,779.60%
-2,511.80%
73.22%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 24.89% vs 31.58% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 10.67% vs 13.65% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Rapid Micro Biosystems, Inc. stock-summary
stock-summary
Rapid Micro Biosystems, Inc.
Industrial Manufacturing
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."